• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析和鉴定 HIV RNase H 在 PPT/U3 连接处切割的特异性的分子决定因素。

Analysis and Molecular Determinants of HIV RNase H Cleavage Specificity at the PPT/U3 Junction.

机构信息

Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid), Campus de Cantoblanco-UAM, 28049 Madrid, Spain.

出版信息

Viruses. 2021 Jan 18;13(1):131. doi: 10.3390/v13010131.

DOI:10.3390/v13010131
PMID:33477685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831940/
Abstract

HIV reverse transcriptases (RTs) convert viral genomic RNA into double-stranded DNA. During reverse transcription, polypurine tracts (PPTs) resilient to RNase H cleavage are used as primers for plus-strand DNA synthesis. Nonnucleoside RT inhibitors (NNRTIs) can interfere with the initiation of plus-strand DNA synthesis by enhancing PPT removal, while HIV RT connection subdomain mutations N348I and N348I/T369I mitigate this effect by altering RNase H cleavage specificity. Now, we demonstrate that among approved nonnucleoside RT inhibitors (NNRTIs), nevirapine and doravirine show the largest effects. The combination N348I/T369I in HIV-1 RT has a dominant effect on the RNase H cleavage specificity at the PPT/U3 site. Biochemical studies showed that wild-type HIV-1 and HIV-2 RTs were able to process efficiently and accurately all tested HIV PPT sequences. However, the cleavage accuracy at the PPT/U3 junction shown by the HIV-2 RT was further improved after substituting the sequence YQEPFKNLKT of HIV-1 RT (positions 342-351) for the equivalent residues of the HIV-2 enzyme (HQGDKILKV). Our results highlight the role of β-sheets 17 and 18 and their connecting loop (residues 342-350) in the connection subdomain of the large subunit, in determining the RNase H cleavage window of HIV RTs.

摘要

HIV 逆转录酶(RT)将病毒基因组 RNA 逆转录成双链 DNA。在逆转录过程中,对 RNase H 切割具有抗性的多聚嘌呤序列(PPT)被用作正链 DNA 合成的引物。非核苷逆转录酶抑制剂(NNRTIs)可以通过增强 PPT 去除来干扰正链 DNA 合成的起始,而 HIV RT 连接亚结构域突变 N348I 和 N348I/T369I 通过改变 RNase H 切割特异性来减轻这种影响。现在,我们证明在已批准的非核苷逆转录酶抑制剂(NNRTIs)中,奈韦拉平和多拉韦林的效果最大。HIV-1 RT 中的 N348I/T369I 组合对 PPT/U3 位点的 RNase H 切割特异性具有显性效应。生化研究表明,野生型 HIV-1 和 HIV-2 RT 能够有效地和准确地处理所有测试的 HIV PPT 序列。然而,HIV-2 RT 在 PPT/U3 连接点的切割准确性在取代 HIV-1 RT 的序列 YQEPFKNLKT(位置 342-351)为 HIV-2 酶的等效残基(HQGDKILKV)后得到进一步提高。我们的结果强调了连接亚结构域中β-片层 17 和 18 及其连接环(残基 342-350)在 HIV RTs 的 RNase H 切割窗口中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/a11449d07c00/viruses-13-00131-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/6ceee3173a9a/viruses-13-00131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/6ee6b9351e67/viruses-13-00131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/97cfffefb414/viruses-13-00131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/f1b4e23adecb/viruses-13-00131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/34c649df4a8e/viruses-13-00131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/c1031f4af9e3/viruses-13-00131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/65c0cceeac5e/viruses-13-00131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/1b400b6599e4/viruses-13-00131-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/a11449d07c00/viruses-13-00131-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/6ceee3173a9a/viruses-13-00131-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/6ee6b9351e67/viruses-13-00131-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/97cfffefb414/viruses-13-00131-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/f1b4e23adecb/viruses-13-00131-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/34c649df4a8e/viruses-13-00131-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/c1031f4af9e3/viruses-13-00131-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/65c0cceeac5e/viruses-13-00131-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/1b400b6599e4/viruses-13-00131-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9ee/7831940/a11449d07c00/viruses-13-00131-g009.jpg

相似文献

1
Analysis and Molecular Determinants of HIV RNase H Cleavage Specificity at the PPT/U3 Junction.分析和鉴定 HIV RNase H 在 PPT/U3 连接处切割的特异性的分子决定因素。
Viruses. 2021 Jan 18;13(1):131. doi: 10.3390/v13010131.
2
Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis.HIV-1逆转录酶连接子域突变对多聚嘌呤序列去除及正链DNA合成起始的影响。
Nucleic Acids Res. 2015 Feb 27;43(4):2259-70. doi: 10.1093/nar/gkv077. Epub 2015 Feb 6.
3
Two modes of HIV-1 polypurine tract cleavage are affected by introducing locked nucleic acid analogs into the (-) DNA template.通过将锁核酸类似物引入(-)DNA模板,HIV-1多聚嘌呤序列切割的两种模式受到影响。
J Biol Chem. 2004 Aug 27;279(35):37095-102. doi: 10.1074/jbc.M403306200. Epub 2004 Jun 25.
4
Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.莫洛尼鼠白血病病毒逆转录酶的核糖核酸酶H C螺旋突变揭示了多聚嘌呤序列识别缺陷。
J Virol. 2002 Aug;76(16):8360-73. doi: 10.1128/jvi.76.16.8360-8373.2002.
5
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.开发并评估针对 HIV-1 逆转录酶 RNase H 活性部位的抑制剂。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.02203-17. Print 2018 Jul 1.
6
In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity.1型人类免疫缺陷病毒多聚嘌呤序列G序列中突变对核糖核酸酶H切割特异性影响的体外分析
Virology. 2007 Apr 10;360(2):341-9. doi: 10.1016/j.virol.2006.10.008. Epub 2006 Nov 21.
7
N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation.HIV-1 逆转录酶中的 N348I 可以抵抗奈韦拉平在正链起始过程中引起的 RNase H 切割偏向。
J Biol Chem. 2010 Aug 27;285(35):26966-26975. doi: 10.1074/jbc.M110.105775. Epub 2010 Jun 8.
8
Major groove binding track residues of the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase enhance cDNA synthesis at high temperatures.人类免疫缺陷病毒 1 型逆转录酶连接亚结构域的大沟结合轨道残基增强 cDNA 在高温下的合成。
Biochemistry. 2013 Dec 23;52(51):9318-28. doi: 10.1021/bi401390x. Epub 2013 Dec 12.
9
HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.HIV-1 逆转录酶连接亚结构域突变与对已批准的非核苷抑制剂的耐药性有关。
Antiviral Res. 2011 Nov;92(2):139-49. doi: 10.1016/j.antiviral.2011.08.020. Epub 2011 Aug 28.
10
Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.人类免疫缺陷病毒1型多聚嘌呤序列5'端的突变会影响核糖核酸酶H的切割特异性和病毒滴度。
J Virol. 2003 Oct;77(20):11150-7. doi: 10.1128/jvi.77.20.11150-11157.2003.

引用本文的文献

1
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription.我可以帮你拿外套吗?HIV-1 衣壳脱壳和逆转录。
Int J Mol Sci. 2024 Jun 28;25(13):7167. doi: 10.3390/ijms25137167.
2
Stephen Oroszlan and Retroviral Proteins.斯蒂芬·奥罗斯兰和逆转录病毒蛋白。
Viruses. 2022 Jan 29;14(2):290. doi: 10.3390/v14020290.

本文引用的文献

1
Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development.在临床开发期间,对参与者中发现的多伟拉韦耐药模式进行综述。
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):635-642. doi: 10.1097/QAI.0000000000002496.
2
Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.不断发展的 HIV-1 逆转录酶结构、功能、抑制和耐药性的认识。
Curr Opin Struct Biol. 2020 Apr;61:113-123. doi: 10.1016/j.sbi.2019.11.011. Epub 2020 Jan 11.
3
Rational Design of Doravirine: From Bench to Patients.
多拉韦林的合理设计:从实验室到患者
ACS Infect Dis. 2020 Jan 10;6(1):64-73. doi: 10.1021/acsinfecdis.9b00178. Epub 2019 Dec 19.
4
Doravirine: First Global Approval.多伟拉韦:全球首次获批。
Drugs. 2018 Oct;78(15):1643-1650. doi: 10.1007/s40265-018-0993-4.
5
Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".对达斯和伯克霍特的回复:“HIV-1 RNA基因组中的多聚嘌呤序列变化如何导致对整合酶抑制剂多替拉韦产生耐药性”
mBio. 2018 May 29;9(3):e00623-18. doi: 10.1128/mBio.00623-18.
6
How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir.HIV-1 RNA基因组中的多嘌呤序列变化如何导致对整合酶抑制剂多替拉韦产生耐药性。
mBio. 2018 Apr 10;9(2):e00006-18. doi: 10.1128/mBio.00006-18.
7
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy.多替拉韦维持治疗失败的患者中 HIV-1 耐药性的动态变化。
J Infect Dis. 2018 Jul 24;218(5):688-697. doi: 10.1093/infdis/jiy176.
8
SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure.SJP-L-5 抑制 HIV-1 多聚嘌呤 tract 引发的正链 DNA 延伸,表明在药物压力下多个部位的病毒 DNA 合成起始。
Sci Rep. 2018 Feb 7;8(1):2574. doi: 10.1038/s41598-018-20954-5.
9
Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid.HIV-1 逆转录酶在 RNA/DNA 杂合分子中切割 RNA 的结构。
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):507-512. doi: 10.1073/pnas.1719746115. Epub 2018 Jan 2.
10
Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.HIV-2 逆转录酶中限制通过切除途径产生核苷类似物耐药性的氨基酸残基。
J Biol Chem. 2018 Feb 16;293(7):2247-2259. doi: 10.1074/jbc.RA117.000177. Epub 2017 Dec 22.